Literature DB >> 3320085

Serum antibodies to outer membrane proteins of Escherichia coli in healthy persons and patients with bacteremia.

A Z Henriksen1, J A Maeland.   

Abstract

Antibodies to Escherichia coli outer membrane proteins in sera from healthy persons and from patients bacteremic with various enteric or nonenteric bacteria were measured by an enzyme-linked immunosorbent assay (ELISA). Outer membranes were prepared from E. coli O55. Serum was absorbed with E. coli O55 lipopolysaccharide and diluted 1:100 for immunoglobulin A (IgA) or IgM and 1:1,000 for IgG antibodies. Paired serum specimens were obtained from the 56 patients included in the study (the first specimen on the day of positive blood culture and the second specimen 8 to 12 days later) and compared with sera from blood donors (n = 50) as controls. On an average, the patients bacteremic with enterobacteria (n = 40) showed increased levels of antibodies of all three immunoglobulin classes in the first serum specimens and significantly higher levels in the second specimens compared with the controls, although with considerable case-to-case variation. Increased levels of IgG antibodies showed the best combination of diagnostic specificity (100%) and sensitivity (53%) for bacteremia caused by enteric bacilli. Mostly, the antibody response was directed against the major E. coli O55 outer membrane proteins at 81,000, 38,500, 33,500, and 7,500 molecular weights as shown by Western blot (immunoblot) analysis. Some of the patients bacteremic with nonenteric bacteria showed increased levels of IgA antibodies, but not of IgG or IgM antibodies. Cross-reactivity of the nonenteric blood culture isolates with the E. coli outer membrane preparation was not demonstrated. The cross-reactivity of the E. coli O55 outer membrane proteins with those of enteric bacilli of other genera was examined by absorption experiments. Western blots with serum absorbed with live E. coli O55 provided evidence that the epitopes of the outer membrane protein at 7,500 molecular weight were available for antibody binding at the bacterial surface, and that at least some of the epitopes of the 38,500- and 33,500-molecular -weight proteins were accessible to antibodies. The results suggest that an ELISA for the measurement of antibodies against cross-reactive outer membrane proteins from enteric bacilli may be useful in the diagnosis of serious infections caused by members of the family Enterobacteriaceae, and that antibodies to the major outer membrane proteins may have an immunobiological function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3320085      PMCID: PMC269436          DOI: 10.1128/jcm.25.11.2181-2188.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  STUDY OF HETEROGENETIC (KUNIN) ANTIBODIES IN SERUM OF HEALTHY SUBJECTS AND CHILDREN WITH ENTERIC AND URINARY TRACT INFECTIONS.

Authors:  H Y WHANG; E NETER
Journal:  J Pediatr       Date:  1963-09       Impact factor: 4.406

2.  Immunoepidemiology of meningococcal disease in military recruits. II. Blocking of serum bactericidal activity by circulating IgA early in the course of invasive disease.

Authors:  J M Griffiss; M A Bertram
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

3.  Antibodies against E. coli O-antigens and common enterobacterial antigen in kidney-transplant recipients. Comparison of antibody findings with evidence of urinary tract infection.

Authors:  O F Thomsen; T Hjort
Journal:  Acta Pathol Microbiol Scand B       Date:  1977-12

4.  Characterization of the major envelope protein from Escherichia coli. Regular arrangement on the peptidoglycan and unusual dodecyl sulfate binding.

Authors:  J P Rosenbusch
Journal:  J Biol Chem       Date:  1974-12-25       Impact factor: 5.157

5.  The major proteins of the Escherichia coli outer cell envelope membrane. Characterization of proteins II* and III, comparison of all proteins.

Authors:  W Garten; I Hindennach; U Henning
Journal:  Eur J Biochem       Date:  1975-11-01

6.  Antibody response to enterobacterial lipoprotein of patients with varied infections due to Enterobacteriaceae.

Authors:  E K Griffiths; S Yoonessi; E Neter
Journal:  Proc Soc Exp Biol Med       Date:  1977-02

7.  Solubilization of the cytoplasmic membrane of Escherichia coli by Triton X-100.

Authors:  C A Schnaitman
Journal:  J Bacteriol       Date:  1971-10       Impact factor: 3.490

8.  Antigenic determinants of murein lipoprotein and its exposure at the surface of Enterobacteriaceae.

Authors:  V Braun; V Bosch; E R Klumpp; I Neff; H Mayer; S Schlecht
Journal:  Eur J Biochem       Date:  1976-03-01

Review 9.  Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria.

Authors:  W R McCabe; S C Bruins; D E Craven; M Johns
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

10.  Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants.

Authors:  M A Johns; S C Bruins; W R McCabe
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

View more
  9 in total

1.  Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection.

Authors:  David Montero; Paz Orellana; Daniela Gutiérrez; Daniela Araya; Juan Carlos Salazar; Valeria Prado; Angel Oñate; Felipe Del Canto; Roberto Vidal
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  A strong antibody response to the periplasmic C-terminal domain of the OmpA protein of Escherichia coli is produced by immunization with purified OmpA or with whole E. coli or Salmonella typhimurium bacteria.

Authors:  R Puohiniemi; M Karvonen; J Vuopio-Varkila; A Muotiala; I M Helander; M Sarvas
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

3.  Naturally occurring anti-Escherichia coli protein antibodies in the sera of healthy humans cause analytical interference in a recombinant nucleocapsid protein-based enzyme-linked immunosorbent assay for serodiagnosis of severe acute respiratory syndrome.

Authors:  Chi Wai Yip; Chung Chau Hon; Fanya Zeng; Ken Y C Chow; Kwok Hung Chan; Joseph S M Peiris; Frederick C C Leung
Journal:  Clin Vaccine Immunol       Date:  2006-11-15

4.  Human Monoclonal Antibodies to Escherichia coli Outer Membrane Protein A Porin Domain Cause Aggregation but Do Not Alter In Vivo Bacterial Burdens in a Murine Sepsis Model.

Authors:  Benjamin D Fowler; Nurgun Kose; Joseph X Reidy; Laura S Handal; Eric P Skaar; James E Crowe
Journal:  Infect Immun       Date:  2022-05-18       Impact factor: 3.609

5.  Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome.

Authors:  H Chart; S M Scotland; B Rowe
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

6.  Semisynthetic Glycoconjugate Vaccine Candidates against Escherichia coli O25B Induce Functional IgG Antibodies in Mice.

Authors:  Arun Naini; Max Peter Bartetzko; Someswara Rao Sanapala; Felix Broecker; Victoria Wirtz; Marilda P Lisboa; Sharavathi G Parameswarappa; Daniel Knopp; Jessica Przygodda; Matthias Hakelberg; Rosalind Pan; Axay Patel; Laurent Chorro; Arthur Illenberger; Christopher Ponce; Srinivas Kodali; Jacqueline Lypowy; Annaliesa S Anderson; Robert G K Donald; Arne von Bonin; Claney L Pereira
Journal:  JACS Au       Date:  2022-08-31

Review 7.  Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field.

Authors:  Jan T Poolman; Michael Wacker
Journal:  J Infect Dis       Date:  2015-09-02       Impact factor: 5.226

8.  Evaluation of truncated LipL32 expressed by Escherichia coli and Pichia pastoris for serodiagnosis of Leptospira infection in rodents.

Authors:  Kanae Shiokawa; Chandika D Gamage; Nobuo Koizumi; Yoshihiro Sakoda; Kenta Shimizu; Yoshimi Tsuda; Kumiko Yoshimatsu; Jiro Arikawa
Journal:  J Vet Med Sci       Date:  2015-09-27       Impact factor: 1.267

9.  Prevalence of non-pneumonic infections with SARS-correlated virus.

Authors:  C W Yip; C C Hon; Fanya Zeng; Ken Y C Chow; Frederick C C Leung
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.